CorMedix (CRMD) Misses Q4 EPS by 1c

CorMedix (NASDAQ: CRMD) reported Q4 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $3.5 thousand.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
• Waste stocks ride AI and healthcare boom as CLH surges 27%